- Home
- GROW vs NOTV Comparison
GROW vs NOTV Comparison
Compare GROW & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROW | NOTV |
|---|---|---|
| Founded | 1968 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.2M | 29.9M |
| IPO Year | N/A | 1997 |
Fundamental Metrics
Financial Performance| Metric | GROW | NOTV |
|---|---|---|
| Price | $2.52 | $0.94 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $5.00 |
| AVG Volume (30 Days) | 41.2K | ★ 1.6M |
| Earning Date | 11-12-2025 | 12-03-2025 |
| Dividend Yield | ★ 3.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.07 | N/A |
| Revenue | $8,546,000.00 | ★ $505,299,000.00 |
| Revenue This Year | N/A | $5.64 |
| Revenue Next Year | N/A | $5.16 |
| P/E Ratio | $37.34 | ★ N/A |
| Revenue Growth | N/A | ★ 0.85 |
| 52 Week Low | $2.02 | $0.66 |
| 52 Week High | $2.78 | $6.48 |
Technical Indicators
Market Signals| Indicator | GROW | NOTV |
|---|---|---|
| Relative Strength Index (RSI) | 51.87 | 40.75 |
| Support Level | $2.24 | $0.77 |
| Resistance Level | $2.33 | $0.86 |
| Average True Range (ATR) | 0.10 | 0.13 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 62.86 | 43.13 |
Price Performance
Historical ComparisonAbout GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.